Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Cat. No. : CSC-SC015139-1
Host Cell : HEK293 Size : >1x106 frozen cells/vial
| Cat. No. | CSC-SC015139-1 |
| Description | This cell line is engineered to stably express human steroid 5 alpha-reductase 2 (SRD5A2) in HEK293 cells. |
| Target Gene | SRD5A2 |
| Gene Species | Homo sapiens (Human) |
| Host Cell | HEK293 |
| Host Cell Species | Homo sapiens (Human) |
| Applications |
1. Gene expression studies 2. Signaling pathway research 3. Drug screening and toxicology 4. Disease research |
| Size | >1x106 frozen cells/vial |
| Stability | Validated for at least 10 passages |
| Quality Control | Negative for bacteria, yeast, fungi and mycoplasma. |
| Storage | Liquid nitrogen |
| Shipping | Dry ice |
| Revival | Rapidly thaw cells in a 37°C water bath. Transfer contents into a tube containing pre-warmed media. Centrifuge cells and seed into a 25 cm2 flask containing pre-warmed media. |
| Media Type | Cells were cultured in DMEM supplemented with 10% fetal bovine serum. |
| Growth Properties | Cells are cultured as a monolayer at 37°C in a humidified atmosphere with 5% CO2. Split at 80-90% confluence, approximately 1:3-1:6. |
| Freeze Medium | Complete medium supplemented with 10% (v/v) DMSO |
| Mycoplasma | Negative |
| Format | One frozen vial containing millions of cells |
| Storage | Liquid nitrogen |
| Safety Considerations |
The following safety precautions should be observed. 1. Use pipette aids to prevent ingestion and keep aerosols down to a minimum. 2. No eating, drinking or smoking while handling the stable line. 3. Wash hands after handling the stable line and before leaving the lab. 4. Decontaminate work surface with disinfectant or 70% ethanol before and after working with stable cells. 5. All waste should be considered hazardous. 6. Dispose of all liquid waste after each experiment and treat with bleach. |
| Ship | Dry ice |
| Gene Name | SRD5A2 steroid-5-alpha-reductase, alpha polypeptide 2 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 2) [ Homo sapiens ] |
| Gene Symbol | SRD5A2 |
| Gene Description | steroid-5-alpha-reductase, alpha polypeptide 2 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 2) |
| GeneID | 6716 |
| Uni ProtID | P31213 |
| mRNA Refseq | NM_000348.3 |
| Protein Refseq | NP_000339.2 |
| Chromosome Location | 2p23 |
| Function | 3-oxo-5-alpha-steroid 4-dehydrogenase activity; progesterone 5-alpha-reductase activity; sterol 5-alpha reductase activity; |
| Pathway | Androgen biosynthesis, organism-specific biosystem; Metabolism, organism-specific biosystem; Metabolism of lipids and lipoproteins, organism-specific biosystem; Metabolism of steroid hormones and vitamins A and D, organism-specific biosystem; Prostate cancer, organism-specific biosystem; Prostate cancer, conserved biosystem; Steroid hormone biosynthesis, organism-specific biosystem; |
| MIM | 607306 |
The Human SRD5A2 (Steroid 5-Alpha-Reductase Type 2) gene encodes an enzyme that catalyzes the conversion of testosterone to dihydrotestosterone, a more potent androgen. SRD5A2 plays a critical role in the development of male reproductive tissues and secondary sexual characteristics. In addition, SRD5A2 is involved in the regulation of androgen levels in the brain, which can impact cognitive function and mood.
The HEK293 cell line has been engineered to stably express the Human SRD5A2 gene. This stable cell line provides a valuable tool for studying the role of SRD5A2 in androgen metabolism and its implications in various physiological and pathological conditions, including male reproductive health, prostate cancer, and cognitive disorders. Researchers can use the HEK293 SRD5A2 stable cell line to investigate the enzyme's activity, its regulation, and its impact on cellular processes. This cell line also serves as a platform for drug metabolism studies and the development of treatments for conditions related to SRD5A2 activity.
The enzyme steroid 5-α reductase (5AR) converts steroids into 5-α reduced metabolites, such as 5-α dihydrotestosterone (DHT) from testosterone. Researchers developed a cell-based assay to evaluate the inhibition of 5AR, crucial for DHT production. IC50 values for inhibitors finasteride and dutasteride were determined using human and fish cell lines via transient overexpression. Fish cell lines showed a lower IC50 for dutasteride than human cell lines, suggesting species-specific responses. This sensitive assay, employing chemical derivatization and LC-MS/MS, exhibits high reproducibility and is suitable for screening endocrine-disrupting chemicals (EDCs). Future studies will explore 5AR inhibition by EDCs across species to elucidate their impact on endocrine pathways.
Figure 1. DHT levels were measured in non-vector-, SRD5A1-HEK293, and SRD5A2-HEK293 cells following testosterone addition. KM values reflecting enzyme affinity were calculated, followed by inhibition assays with finasteride and dutasteride to determine IC50 values (Kim D, et al., 2021).
Human SRD5A2 Stable Cell Line - HEK293 is engineered to stably express steroid 5 alpha-reductase 2, an enzyme that plays a pivotal role in the conversion of testosterone into the more potent dihydrotestosterone (DHT). This conversion is crucial for the development and maintenance of male secondary sexual characteristics and also plays a role in the pathophysiology of several diseases.
(1)Drug Development for Prostate Diseases
This cell line is instrumental for screening and evaluating novel inhibitors of SRD5A2 that could be used for the treatment of benign prostatic hyperplasia (BPH) and prostate cancer. By inhibiting the conversion of testosterone to DHT, the progression of prostate enlargement and malignancy can potentially be controlled or slowed.
(2)Research on Androgenic Alopecia
The Human SRD5A2 Stable Cell Line - HEK293 can also be used in the study of androgenic alopecia, commonly known as male pattern baldness. Researchers can test the efficacy of topical treatments aimed at reducing DHT levels in the scalp and thus slowing or reversing hair loss.
(3)Understanding Hormonal Regulation and Sexual Differentiation
The cell line provides a consistent model to explore the role of androgens in sexual differentiation and development. It allows for the in vitro study of genetic disorders of sexual development, such as 5-alpha-reductase deficiency, contributing to a better understanding of this enzyme's function in physiological and pathological conditions.
A: The role of the Human SRD5A2 Stable Cell Line - HEK293 in studying androgen metabolism is to provide an experimental platform to investigate how the SRD5A2 enzyme catalyzes the conversion of testosterone to dihydrotestosterone, a process crucial for the male reproductive system and prostate health. This cell line helps elucidate the role of the SRD5A2 gene in androgen-related diseases, such as prostate cancer and benign prostatic hyperplasia.
A: The role of the Human SRD5A2 Stable Cell Line - HEK293 in studying androgen receptor signaling is to investigate how the stable expression of the SRD5A2 enzyme affects the activation and signaling of androgen receptors. This cell line helps reveal the role of SRD5A2 in regulating androgen signals and cellular functions, which is crucial for understanding the molecular mechanisms of androgen-related diseases.
A: The role of the Human SRD5A2 Stable Cell Line - HEK293 in identifying potential therapeutic targets for androgen-related diseases is to provide an experimental model for evaluating the impact of SRD5A2 enzyme inhibitors on disease progression. This cell line aids in discovering new therapeutic strategies, especially in the development of treatments for prostate cancer and benign prostatic hyperplasia.
A: The role of the Human SRD5A2 Stable Cell Line - HEK293 in studying the effects of androgens on cell proliferation is to simulate the role of androgens in cell growth and differentiation by stably expressing the SRD5A2 enzyme. This cell line helps understand the function of SRD5A2 in regulating cell growth and maintaining tissue homeostasis, which is significant for developing treatments that inhibit excessive cell proliferation.
A: The stable expression of the SRD5A2 gene in the Human SRD5A2 Stable Cell Line - HEK293 is achieved by integrating the SRD5A2 gene into the genome of HEK293 cells, using selective markers and screening strategies. This typically involves the use of viral vectors, such as retroviruses or lentiviruses, and antibiotic resistance genes as selection markers, thereby creating a cellular model that continuously expresses the SRD5A2 protein.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
Provides a platform for developing therapeutic drugs targeting SRD5A2-related diseases.
Contributes to understanding the association between SRD5A2 gene mutations and disease development.
The Human SRD5A2 Stable Cell Line - HEK293 aids in studying the role of the SRD5A2 gene in hormone metabolism.
Enhances knowledge of related physiological processes by studying the function of SRD5A2 within cells.
Write a review of your use of Biogene products and services in your research. Your review can help your fellow researchers make informed purchasing decisions.